Bevacizumab therapy in advanced non-small cell lung cancer (NSCLC): Outcomes from a community oncology network.

被引：0
|
作者：
Neubauer, M. A.
Garey, J. S.
Nelson, G. C.
Patt, D. A.
Cartwright, T. H.
Hoverman, J. R.
Busby, L. T.
Brooks, B. D.
Sitarik, M. A.
Kolodziej, M. A.
Anderson, R. W.
Beveridge, R. A.
机构：
[1] US Oncol, Kansas City Canc Ctr, The Woodlands, TX USA
[2] US Oncol Pathways Task Force, The Woodlands, TX USA
[3] US Oncol, The Woodlands, TX USA
[4] Ocala Oncol, Ocala, FL USA
[5] US Oncol, Texas Oncol, The Woodlands, TX USA
[6] US Oncol, Rocky Mt Canc Ctr, Boulder, CO USA
[7] US Oncol, New York Hematol Oncol, Albany, NY USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2011年 / 29卷 / 15期
关键词：
D O I：
10.1200/jco.2011.29.15_suppl.e16527
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e16527
引用
收藏
页数：1
相关论文
共 50 条
  • [21] ERLOTINIB IN ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC) TREATMENT
    Goncalves, Ivone M.
    Monteiro, Regina
    Neves, Sofia
    Conde, Sara
    Campainha, Sergio
    Parente, Barbara
    JOURNAL OF THORACIC ONCOLOGY, 2011, 6 (06) : S1298 - S1298
  • [22] Gemcitabine and cisplatin for advanced non-small cell lung cancer (NSCLC)
    Casal, J
    Grande, C
    Caeiro, M
    EUROPEAN JOURNAL OF CANCER, 1997, 33 : 1083 - 1083
  • [23] Bevacizumab in Non-Small Cell Lung Cancer
    Francesco Di Costanzo
    Francesca Mazzoni
    Marinella Micol Mela
    Lorenzo Antonuzzo
    Daniele Checcacci
    Matilde Saggese
    Federica Di Costanzo
    Drugs, 2008, 68 : 737 - 746
  • [24] Bevacizumab in non-small cell lung cancer
    Di Costanzo, Francesco
    Mazzoni, Francesca
    Mela, Marinella Micol
    Antonuzzo, Lorenzo
    Checcacci, Daniele
    Saggese, Matilde
    Di Costanzo, Federica
    DRUGS, 2008, 68 (06) : 737 - 746
  • [25] Bevacizumab in non-small cell lung cancer
    Sandler, Alan
    CLINICAL CANCER RESEARCH, 2007, 13 (15) : 4613S - 4616S
  • [26] PHYSICAL TARGETING OF LOCALLY ADVANCED NON-SMALL CELL LUNG CANCER (NSCLC): PROTON THERAPY
    Cox, James D.
    Quynh Nguyen
    Allen, Pamela
    Ly, Ngoc B.
    Gomez, Daniel
    Chang, Joe
    Liao, Zhongxing
    Tsao, Anne
    Komaki, Ritsuko
    Lu, Charles
    JOURNAL OF THORACIC ONCOLOGY, 2013, 8 : S597 - S597
  • [27] Molecular targeted therapy in the treatment of advanced stage non-small cell lung cancer (NSCLC)
    Kumarakulasinghe, Nesaretnam Barr
    van Zanwijk, Nico
    Soo, Ross A.
    RESPIROLOGY, 2015, 20 (03) : 370 - 378
  • [28] Induction Therapy Followed by Surgery for Non-Small Cell Lung Cancer (NSCLC) in a Community Cancer Center
    Dalton, B. G.
    Hird, R. B.
    Orr, R. K.
    Nguyen, C. L.
    ANNALS OF SURGICAL ONCOLOGY, 2013, 20 : S110 - S110
  • [29] Pemetrexed and carboplatin plus bevacizumab with maintenance pemetrexed and bevacizumab as first-line therapy for advanced non-squamous non-small cell lung cancer (NSCLC)
    Patel, J. D.
    Hensing, T. A.
    Rademaker, F.
    Hart, E.
    Obasaju, C. K.
    Treat, J.
    Milton, D.
    Bonomi, P. D.
    JOURNAL OF CLINICAL ONCOLOGY, 2008, 26 (15)
  • [30] Advanced non-small cell lung cancer - pioneer in personalized oncology
    Saalfeld, Felix Carl
    Aust, Daniela E.
    Wermke, Martin
    DEUTSCHE MEDIZINISCHE WOCHENSCHRIFT, 2023, 148 (18) : 1166 - 1173
12345